Found 834 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) PHASE1 Primary trial objective in this single arm trial is to assess the safety an...
Show More Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor PHASE1 To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer PHASE2 In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma PHASE1 Monoclonal antibodies can locate tumor cells and either kill them or delive...
Show More Location
Children's Oncology Group
Learn More & Join Trial
Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction PHASE1 Evaluation of The Efficacy And Safety of Tislelizumab (PD-1) Monoclonal Ant...
Show More Location
Multiple Locations
Learn More & Join Trial
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma PHASE1 The goal of the Phase I part of this clinical research study is to find the...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes PHASE2 Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Show More Location
Service d'Endocrinologie Pédiatrique
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Non-specific Response to H1N1 Vaccine N/A This is a prospective observational study with recruitment of healthy volun...
Show More Location
University Clinic of Respiratory and Allergic Diseases
Learn More & Join Trial